We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

By HospiMedica International staff writers
Posted on 01 May 2024
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately 99,000 deaths each year. Pathogens on surfaces can survive for days to months, and studies indicate that 50% of surfaces in healthcare settings are not adequately disinfected during manual cleaning processes. The financial burden of HAIs on the U.S. healthcare system is estimated to be between USD 28 billion to USD 33 billion annually. Now, the results of an in-hospital disinfection study involving the use of novel handheld Filtered Far UV-C devices have demonstrated their effectiveness in quickly reducing HAI-causing pathogens on high-touch clinical surfaces, addressing a significant challenge in hospital settings where traditional manual disinfection methods often fall short.

The research, conducted at The University of Texas MD Anderson Cancer Center (Houston, TX, USA), utilized handheld Filtered Far UV-C devices provided by Freestyle Partners (Detroit, MI, USA). The study showed a significant reduction in surface pathogens that cause HAIs within the clinical areas of hematologic malignancy and stem cell units. Filtered Far UV-C, a safe form of disinfection technology, uses invisible germicidal light that kills viruses, bacteria, spores, and fungi almost instantly, eliminating the need for the 2–10-minute dwell times required by chemical disinfectants. These devices offer a no-touch disinfection solution, particularly advantageous where manual cleaning is not feasible. This study further confirms the efficacy and speed of these devices in reducing dangerous pathogens on high-touch surfaces, thanks to their patented technology that ensures proper usage and achieves desired disinfection results.

“This study provides further real-world data on the efficacy of handheld Filtered Far UV-C devices to reduce surface pathogens which we hope could ultimately improve patient care and tackle the tremendous expenses healthcare institutions face in fighting HAIs,” said Jennifer Rosen, co-founder of Freestyle Partners, LLC.

Related Links:
The University of Texas MD Anderson Cancer Center
Freestyle Partners

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Monitor/Defibrillator
Zenix

Channels

Critical Care

view channel
Image Credit: iStock

Intraoperative Drug Combination Reduces Kidney Injury in Septic Shock Surgery

Septic shock is a life-threatening response to infection that can cause circulatory failure and organ injury, with global mortality rates reaching 50%. Although emergency surgery can clear the underlying... Read more

Surgical Techniques

view channel
Image: The LUCID prototype, which combines a miniature ultrasound device with a fluid-delivery tube, an osmotic pump and custom electronics. A coin provides a sense of scale. The system is designed to deliver substances directly into brain tissue and uses ultrasound to help them spread. (Photo courtesy of MIT)

Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma

Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more